<DOC>
	<DOCNO>NCT01978613</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate safety , tolerability pharmacokinetics ( exposure trial drug body ) multiple dose NNC0113-0987 oral formulation healthy subject .</brief_summary>
	<brief_title>Investigation Safety , Tolerability Pharmacokinetics Multiple Doses NNC0113-0987 Oral Formulation Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Male subject , consider generally healthy , base medical history , physical examination , result vital sign , electrocardiogram laboratory safety test perform screen visit , judge investigator Age 1864 year ( inclusive ) time sign informed consent Body mass index ( BMI ) : 20.029.9 kg/m^2 ( inclusive ) History , presence , cancer , diabetes clinically significant cardiovascular , respiratory , metabolic , renal , hepatic , gastrointestinal , endocrinological , haematological , dermatological , venereal , neurological , psychiatric disease major disorder , judge investigator Personal family history medullary thyroid carcinoma multiple endocrine neoplasia syndrome type 2 History chronic pancreatitis idiopathic acute pancreatitis Subject previous gastrointestinal surgery , except subject underwent uncomplicated surgical procedure appendectomy , hernia surgery , biopsy , well colonic gastric endoscopy Use prescription nonprescription medicinal product herbal product ( except routine vitamin ) within three week precede dosing period . Occasional use paracetamol acetylsalicylic acid permit</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>